Phosphorylation site mutated RB exerts contrasting effects on apoptotic response to different stimuli

A Masselli1, J Y J Wang

  • 1Division of Hematology-Oncology and Moores Cancer Center, Department of Medicine, UCSD School of Medicine, Health Sciences Drive, University of California San Diego, La Jolla, CA 92093, USA.

Oncogene
|October 6, 2005
PubMed

Insights

Phosphorylation site mutated retinoblastoma protein (PSM-RB) differentially affects apoptosis. PSM-RB expression attenuated doxorubicin-induced apoptosis but enhanced TNF-induced apoptosis, decoupling cell cycle arrest from apoptosis resistance.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The retinoblastoma tumor-suppressor protein (RB) is crucial for cell cycle regulation and apoptosis.
  • Phosphorylation of RB by cyclin-dependent kinases controls cell cycle progression.
  • Mutations in RB phosphorylation sites (PSM-RB) can lead to cell cycle arrest.

Purpose of the Study:

  • To investigate the impact of inducible PSM-RB expression on apoptosis induced by doxorubicin (DOXO), staurosporine (STS), and tumor necrosis factor (TNF) in Rat-16 cells.
  • To determine if cell cycle arrest mediated by PSM-RB correlates with resistance to apoptosis.
  • To elucidate the differential roles of PSM-RB in response to various apoptotic stimuli.

Main Methods:

  • Inducible expression of PSM-RB in Rat-16 cells.
  • Treatment with three distinct death stimuli: DOXO, STS, and TNF.
  • Assessment of caspase activation as a marker of apoptosis.
  • Monitoring of cell cycle progression.

Main Results:

  • Induced PSM-RB expression attenuated DOXO-induced caspase activation, linked to G1 cell cycle arrest.
  • PSM-RB expression did not inhibit STS-induced caspase activation, despite potential for RB-dependent G1 arrest.
  • PSM-RB expression unexpectedly promoted TNF-induced apoptosis in cells that typically undergo necrosis.

Conclusions:

  • PSM-RB exhibits context-dependent effects on apoptosis, varying with the death stimulus.
  • Cell cycle arrest induced by PSM-RB does not invariably confer resistance to apoptosis.
  • RB phosphorylation status significantly influences cellular responses to apoptotic signals.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.